Richard Studwell, Non Executive Director, bought 1,000 shares in the company on the 17th March 2020 at a price of 263.00p. The Director now holds...

UBS today reaffirms its buy investment rating on Rolls-Royce Group PLC (LON:RR.) and cut its price target to 664p (from 886p).

Broker Forecasts data provided...

James Dickson, Chairman, bought 15,000 shares in the company on the 16th March 2020 at a price of 100.00p. The Director now holds 5,034,981 shares....

Simon Holden, Non Executive Director, bought 17,500 shares in the company on the 17th March 2020 at a price of 149.30p. The Director now holds...

Christopher Townsend, Non Executive Director, bought 15,000 shares in the company on the 13th March 2020 at a price of 745.00p. The Director now holds...

Christopher Townsend, Non Executive Director, bought 25,000 shares in the company on the 16th March 2020 at a price of 713.00p. The Director now holds...

Drug discovery company E-therapeutics narrowed full-year losses as it cut back on R&D and administrative spending.

Pre-tax losses for the year through January amounted to...

William Simpson, Non Executive Director, bought 18,000 shares in the company on the 13th March 2020 at a price of 175.00p. The Director now holds...

Stephen Davidson, Non Executive Director, bought 1,600 shares in the company on the 17th March 2020 at a price of 470.00p. The Director now holds...

UBS today reaffirms its sell investment rating on Meggitt PLC (LON:MGGT) and cut its price target to 379p (from 478p).

Broker Forecasts data provided by...